Skip to content

effectiveness of taping in knee osteoarthritis

Effects of Taping on Pain and Functional Outcome in Patients with Knee Osteoarthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015041021673N1
Enrollment
44
Registered
2015-04-30
Start date
2014-05-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis. Other primary gonarthrosis

Interventions

Intervention 1: control: cap celecoxib 100mg, 1-3 capsules per day (based on pain severity). Intervention 2: control: exercise(stretching for hamstring and calf muscle and strengthening for quadriceps
Treatment - Drugs
Rehabilitation
control: cap celecoxib 100mg, 1-3 capsules per day (based on pain severity)
control: exercise(stretching for hamstring and calf muscle and strengthening for quadriceps femoris)
intervention: exercise(stretching for hamstring and calf muscle and strengthening for quadriceps femoris)
intervention : cap celecoxib 100mg 1-3 daily(based on pain severity)
intervention: knee taping

Sponsors

Isfahan Univercity of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: knee OA with radiological grade I,III or III (based on Kellgren-Lawrence grading scale); no presence of any inflammatory arthritis; no history of any injection at knee or any surgical intervention in this part within the last 6-month; no suspicion to other pathologies in the knee; not severe obesity; no instability of the knee joint; no cardiovascular disorders (due to cardiovascular side-effect of celecoxib); no trauma to the knee during the study; Exclusion criteria: allergic reaction to tape or any skin problem that prevents the tape; not following the treatment by patients; performing physiotherapy within treatment schedule

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: 0-3w-6w. Method of measurement: VAS Score.;Timed Up and Go. Timepoint: 0-3w-6w. Method of measurement: The patient is observed and timed while he rises from an arm chair, walks 3 meters, turns, walks back, and sits down again.;Step test. Timepoint: 0-3w-6w. Method of measurement: The Step Test involves stepping one foot on, then off, a block as quickly as possible in 15 seconds.

Secondary

MeasureTime frame
Weekly mean of analgesics consumption. Timepoint: 0-3w-6w. Method of measurement: mean number of Celecoxib 100mg capsules consumpted at last week.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahboobeh Mashayekhi Asl

Isfahan University of Medical Sciences

m.mashayekhi.asl@med.mui.ac.ir+98 31 3443 9361

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026